|
|
|
|
B
Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, Illinois (S.C.P, D.M.H, V.R.); and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, New York (J.F.S, A.L.W, S.B.M)
The expression of inducible nitric-oxide synthase (iNOS) in vascular smooth
muscle cells leads to prolonged vasorelaxation in vivo and contributes to the
profound vasodilation induced by bacterial lipopolysaccharide (LPS) in septic
shock. This induction of iNOS depends, in large part, on activation of nuclear
factor (NF)-
B. Hypertonicity regulates the activity of NF-
B in
different cell lines; as such, we propose that it should also regulate the
expression of iNOS. Thus, the goal of this study was to determine whether
hypertonicity regulates iNOS expression and function in smooth muscle cells
and to elucidate the mechanism(s) underlying this process. Treatment of
hamster ductus deferens (DDT1MF-2) cells and porcine aortic smooth
muscle cells with either mannitol (50 mM) or NaCl (50 mM) reduced
LPS-stimulated iNOS expression and nitric oxide release. Both of these agents
also reduced the activation of NF-
B induced by LPS, tumor necrosis
factor-
and interleukin-1
in smooth muscle cells. This inhibitory
action was caused by suppression of I
B-
phosphorylation, a
prerequisite for ubiquitination and degradation of this protein, and showed
additivity with N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal
(MG-132), an inhibitor of proteasomal degradation of I
B-
.
Furthermore, exposure to mannitol inhibited the activity of I
B kinase,
an enzyme involved in phosphorylation of I
B-
. Mannitol was
unable to affect the induction of iNOS produced by overexpression of RelA in
DDT1MF-2 cells, suggesting that this agent does not have additional
downstream inhibitory actions on this activated NF-
B subunit. Taken
together, these data suggest that these hypertonic solutions may prove useful
as anti-inflammatory agents, especially against conditions associated with
increased NF-
B activity.
Received September 16, 2002; accepted February 24, 2003.
Address correspondence to: Dr. Vickram Ramkumar, SIU School of Medicine, Box 19230, Springfield, IL 62974-1222. E-mail: vramkumar{at}siumed.edu
This article has been cited by other articles:
![]() |
U. Hasler Controlled aquaporin-2 expression in the hypertonic environment Am J Physiol Cell Physiol, April 1, 2009; 296(4): C641 - C653. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pingle, S. Jajoo, D. Mukherjea, L. F. Sniderhan, K. A. Jhaveri, A. Marcuzzi, L. P. Rybak, S. B. Maggirwar, and V. Ramkumar Activation of the Adenosine A1 Receptor Inhibits HIV-1 Tat-Induced Apoptosis by Reducing Nuclear Factor-{kappa}B Activation and Inducible Nitric-Oxide Synthase Mol. Pharmacol., October 1, 2007; 72(4): 856 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y.H. Chan, C.-C. Ou, L.-L. Wang, and S. H.H. Chan Heat Shock Protein 70 Confers Cardiovascular Protection During Endotoxemia via Inhibition of Nuclear Factor-{kappa}B Activation and Inducible Nitric Oxide Synthase Expression in the Rostral Ventrolateral Medulla Circulation, December 7, 2004; 110(23): 3560 - 3566. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Pingle, S. Mishra, A. Marcuzzi, S. G. Bhat, Y. Sekino, L. P. Rybak, and V. Ramkumar Osmotic Diuretics Induce Adenosine A1 Receptor Expression and Protect Renal Proximal Tubular Epithelial Cells against Cisplatin-mediated Apoptosis J. Biol. Chem., October 8, 2004; 279(41): 43157 - 43167. [Abstract] [Full Text] [PDF] |
||||